Titlebook: Managing Acute Coronary Syndromes in Clinical Practice; Anthony A Bavry,Deepak L Bhatt Book 2008 Springer Healthcare Ltd. 2008 Acute Coron

思考

AUGUR

Anti-platelet therapies,long with mechanical or chemical reperfusion. Patients who are not candidates for revascularization may only receive medical treatment for their ACS. Cardiovascular drugs are given with the expectation that they will produce a significant beneficial effect. For some drugs in certain groups of patien

遺忘

枕墊

Miscellaneous therapies,ent, especially during reperfusion therapy. However, other therapies, such as statins, beta-blockers and ACE inhibitors are also important. These therapies not only help to limit infarct size and reduce recurrent myocardial infarction, but also improve survival.

粗俗人

Revascularization and reperfusion therapy,y. The former takes place in non-ST-elevation or ST-elevation ACS, while reperfusion is employed only for ST-elevation myocardial infarction. Revascularization therapy for non-ST-elevation ACS is usually considered an urgent condition unless there are signs of hemodynamic or electrical instability,

Dysarthria

Controversies and future approaches, While this is good, we are reminded that there are numerous areas in the management of ACS that remain somewhat controversial or unsettled. This uncertainty in the optimal management of unstable coronary patients is a fertile area for continued debate and future research. In this chapter, the first

技術(shù)

廣告

鴕鳥(niǎo)

樂(lè)意

Anthony A Bavry,Deepak L Bhattomobilbau, Chemie und Medizin-Technik auseinandergesetzt. Die dabei skizzierte Marktexpansion ist für alle drei Branchen nicht nur mit vielversprechenden Perspektiven verbunden, sie kann sogar dazu beitragen, dass indirekt auch die Wettbewerbsf?higkeit im klassischen Gesch?ft auf Dauer verbessert od